Pharmacotherapy of aphasia: Myth or reality?

@article{Boissezon2007PharmacotherapyOA,
  title={Pharmacotherapy of aphasia: Myth or reality?},
  author={X. D. Boissezon and P. P{\'e}ran and C. D. Boysson and J. D{\'e}monet},
  journal={Brain and Language},
  year={2007},
  volume={102},
  pages={114-125}
}
Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents. Here, we reviewed the MEDLINE available reports of drug therapy for aphasia. So far, proofs of efficiency were found indubitable for none of the studied molecules. However, some of them showed limited efficiency (piracetam and amphetamine). Moreover, drug therapies for aphasia were less efficient alone than when they were… Expand
Is recurrent perseveration a product of deafferented functional systems with otherwise normal post-activation decay rates?
TLDR
How various proposals from theory, from the clinic and from drug therapy interact and compete in the search for a cause or causes of recurrent perseveration is discussed and evaluated. Expand
Dopaminergic therapy in aphasia
TLDR
The evidence for the efficacy of dopaminergic agents in aphasia therapy is mixed and further trials with better tolerated agents are required. Expand
Adjunctive Approaches to Aphasia Rehabilitation: A Review on Efficacy and Safety
TLDR
Although the review reveals an extraordinary variability among the different studies, substantial agreement has been reached on some general principles, such as the necessity to consider tDCS only as an adjunct to traditional language therapy. Expand
Crossover Trial of Subacute Computerized Aphasia Therapy for Anomia With the Addition of Either Levodopa or Placebo
TLDR
Administration of levodopa for 2 weeks during the postacute stage of aphasia did not augment the positive effects of subacute intensive language treatment with CAT for a spoken naming task. Expand
Drug Therapy of Post-Stroke Aphasia: A Review of Current Evidence
TLDR
Preliminary data reveals that combining neuroscience-based intensive aphasia techniques and drugs acting on cholinergic and glutamatergic neurotransmitter systems are associated with better outcomes than other strategies and long-term maintenance of benefits. Expand
Psycholinguistics of aphasia pharmacotherapy: Asking the right questions
TLDR
It is suggested that the inclusion of theory-driven linguistic measures in aphasia pharmacotherapy studies would add an important step toward elucidating precise patterns of improvement in language performance resulting from pharmacotherapeutic intervention. Expand
Innovative Approaches to Aphasia Rehabilitation: a Review on Efficacy, Safety and Controversies
Aphasia is one of the most socially disabling post-stroke deficits. Although traditional therapies have been shown to induce adequate clinical improvement, aphasic symptoms often persist. Therefore,Expand
Pharmacotherapy to Improve the Acquired Aphasia following Brain Damages: A Review Study
TLDR
Although existing evidence has proved the pivotal role of pharmacotherapy in treatment of aphasia after acquired brain lesions in adults, further research is required to assure the clinicians in using pharmacotherapy as a standard approach in treatment with aphasic patients. Expand
Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
TLDR
Piracetam taken orally in a daily dose of 4.8 g for 6 months has no clear beneficial effect on post-stroke language disorders. Expand
Effect of Donepezil on Wernicke Aphasia After Bilateral Middle Cerebral Artery Infarction: Subtraction Analysis of Brain F-18 Fluorodeoxyglucose Positron Emission Tomographic Images.
TLDR
It is suggested that donepezil can be an effective therapeutic choice for the treatment of Wernicke aphasia, after the old infarction in the territory of left middle cerebral artery for 8 years and the recent infarctions in the right middle cerebral arteries for 4 months. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 47 REFERENCES
Pharmacotherapy for aphasia
TLDR
This work attempted to restore speech fluency in a patient with long-standing transcortical motor aphasia by treating his symptoms of hesitancy and impaired initiation of speech with bromocriptine. Expand
Transient improvement of aphasia with zolpidem.
TLDR
A 52-year-old right-handed woman, who had a stroke that affected her left insula, putamen, and superior temporal gyrus, was prescribed zolpidem, and ingestion of the first dose was followed by a dramatic improvement in her speech, which persisted for three years. Expand
Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia.
TLDR
Bromocriptine was found to be ineffective for the treatment of any symptoms of chronic nonfluent aphasia. Expand
Pharmacotherapy of aphasia. A critical review.
TLDR
While drug therapy is unlikely to revolutionize the treatment of aphasia, it nonetheless holds promise as an adjunct to behavioral speech and language therapy to decrease performance variability and consequently to improve mean performance in patients with mild to moderate language dysfunction. Expand
Bromocriptine treatment of nonfluent aphasia.
TLDR
Bromocriptine is not recommended as monotherapy for the treatment of chronic nonfluent aphasia because it did not significantly improve the patient's speech fluency, language content, overall degree of aphasic severity, or nonverbal cognitive abilities. Expand
Bromocriptine treatment of nonfluent aphasia
TLDR
Bromocriptine is not recommended as monotherapy for the treatment of chronic nonfluent aphasia because it did not significantly improve the patients' speech fluency, language content, overall degree of aphasic severity, or nonverbal cognitive abilities. Expand
An Open-Label Trial of Bromocriptine in Nonfluent Aphasia: A Qualitative Analysis of Word Storage and Retrieval
TLDR
Bromocriptine may be a useful adjunct in the treatment of selected patients with a nonfluent aphasia in which retrieval deficits play a major role. Expand
Restitution of alpha-topography by piracetam in post-stroke aphasia.
TLDR
Neuropsychological scores improved significantly and markedly in various domains of speech during piracetam treatment, whereas improvements were less marked and restricted to a few categories in the placebo group. Expand
Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke
TLDR
High dosage of BR promoted a late recovery in stable chronic non-fluent aphasia and this improvement was enhanced by combination with ST. Expand
Treatment efficacy: aphasia.
TLDR
The conclusion of this review is that, generally, treatment for aphasia is efficacious. Expand
...
1
2
3
4
5
...